3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Venous Thromboembolism
1
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Myeloproliferative Disorders
1
Interventions
apixaban
22
Rivaroxaban
16
Dalteparin
16
Enoxaparin
11
Heparin, Low-Molecular-Weight
10
Tinzaparin
8
Aspirin
8
Fondaparinux
4
Dabigatran
4
edoxaban
3
Warfarin
3
Nadroparin
3
bemiparin
2
abelacimab
2
Rosuvastatin Calcium
2
Observation
2
MAA868
2
sotorasib
1
ribociclib
1
reviparin
1
palbociclib
1
isoquercitrin
1
enoxaparin sodium
1
certoparin
1
calcium heparin
1
betrixaban
1
argatroban
1
acarboxyprothrombin
1
abemaciclib
1
Tacrolimus
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Venous Thromboembolism
×
Tablets
×
Classical hematology
×
Clear all
NCT04243122
2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2
Completed
44 enrolled